Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues
Revenues	$ 1,535	$ 1,544
Total revenues	1,535	1,544
Expenses
Research and Development Expense	2,717	2,637
Manufacturing expense	2,256	1,477
Selling, general and administrative expense	3,753	2,960
Depreciation of tangible assets	791	734
Total expenses	9,517	7,808
Operating loss	(7,982)	(6,264)
Finance and interest income	152	422
Financing and interest expense	(1,488)	(1,202)
Net financing and interest expense	(1,336)	(780)
Loss before income taxes	(9,318)	(7,044)
Deferred income tax	6	0
Net loss	(9,312)	(7,044)
Other comprehensive (loss) income
Change in fair value	(7)	102
Foreign currency translation adjustment	(508)	(122)
Total other comprehensive income (loss)	(515)	(20)
Comprehensive loss	$ (9,827)	$ (7,064)
Basic and diluted:
Weighted average number of shares outstanding (in shares)	137,003,313	108,440,888
Basic and diluted loss per common share (in dollars per share)	$ (0.07)	$ (0.07)